FDA Approves Wearable Infusion Device for Advanced Parkinson Disease

FDA Approves Onapgo (apomorphine hydrochloride) for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease

drugs.com - 04/Feb 18:02

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson's Disease

healthtechzone.com - 04/Feb 14:00

FDA Approves Susvimo for Diabetic Macular Edema

drugs.com - 05/Feb 23:02

WEDNESDAY, Feb. 5, 2025 -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular...

FDA Approves Symbravo for Acute Treatment of Migraine in Adults

drugs.com - 05/Feb 23:02

WEDNESDAY, Feb. 5, 2025 -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine...

FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

oncologynews.com.au - 02/Feb 01:25

On January 16, 2025, the Food and Drug Administration approved sotorasib with panitumumab for adult patients with KRAS G12C-mutated metastatic...

FDA Approves Esketamine Nasal Spray for Resistant Depression

medindia.net - 28/Jan 10:32

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive...

FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer

drugs.com - 03/Feb 16:14

MONDAY, Feb. 3, 2025 -- The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with...

FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Treatment of Diabetic Macular Edema

drugs.com - 04/Feb 00:02

South San Francisco, CA -- February 4, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food...

FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra

drugs.com - 30/Jan 23:01

JERSEY CITY, N.J., Jan. 30, 2025 -- Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved Avtozma® (CT-P47,...

FDA Approves Journavx (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

drugs.com - 30/Jan 02:01

BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration...

Rubriques :